Published in Medical Letter on the CDC and FDA, October 1st, 2006
"Tumor susceptibility gene 101 (TSG101) encodes a host cellular protein that is appropriated by human immunodeficiency virus type 1 (HIV-1) in the budding process of viral particles from infected cells.
"Variation in the coding or noncoding regions of the gene could potentially affect the degree of TSG101-mediated release of viral particles," scientists writing in the Journal of Virology report.
According to A.A. Bashirova and colleagues...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.